Imagion Biosystems Limited

ASX:IBX.AX

0.05 (AUD) • At close November 4, 2024
Bedrijfsnaam Imagion Biosystems Limited
Symbool IBX.AX
Munteenheid AUD
Prijs 0.053
Beurswaarde 2,281,051
Dividendpercentage 0%
52-weken bereik 0.022 - 0.48
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. Isaac J. Bright M.D.
Website https://imagionbiosystems.com

An error occurred while fetching data.

Over Imagion Biosystems Limited

Imagion Biosystems Limited provides medical imaging technologies based on superparamagnetic relaxometry for cancer and disease detection, and monitoring therapy. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX,

Vergelijkbare Aandelen

Dimerix Limited logo

Dimerix Limited

DXB.AX

0.385 AUD

Pharmaxis Ltd logo

Pharmaxis Ltd

PXS.AX

0.028 AUD

Patrys Limited logo

Patrys Limited

PAB.AX

0.003 AUD

PainChek Limited logo

PainChek Limited

PCK.AX

0.033 AUD

Vectus Biosystems Limited logo

Vectus Biosystems Limited

VBS.AX

0.08 AUD

Imricor Medical Systems, Inc. logo

Imricor Medical Systems, Inc.

IMR.AX

0.745 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)